PL04.13 Aumolertinib Maintenance after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer: Interim Results of the Phase III Study (POLESTAR)
Jinming Yu(Shandong Tumor Hospital), Chunyu Liu(Central South University), Ou Jiang(Fox Chase Cancer Center), Bin Xu(Fudan University), Qiaoli Lin(First Affiliated Hospital of Xiamen University), Yu Yao(Qinghai University), Congying Xie(Wenzhou Medical University), Shundong Cang(Henan University), Jian Yin(Chinese Academy of Medical Sciences & Peking Union Medical College), Gang Wu(Hubei University of Chinese Medicine), H. Li(Hefei First People's Hospital), Xun Zhang(Jiangsu University), Ke Lü(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuyang Xu(Zhejiang University), Kai Yang(Harbin Medical University), Xiaorong Dong(The University of Melbourne), Aiping Shi(First Bethune Hospital of Jilin University), Jianxiang Shi, Gongwei Wang(Peking University), Jie Fang(Xi'an Jiaotong University), Jie Chen(Shandong University of Technology), Qing Liu(Wuhan University), Xing Li(Xinjiang Medical University), Bin Liu(Shaanxi Science and Technology Department), Jian Li(Discovery Institute), Jie Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zheng Zhang(East China Normal University), Yufeng Cheng(The Affiliated Yongchuan Hospital of Chongqing Medical University), Sheng Ye(Shanghai University), Xue Meng(Shandong Tumor Hospital), Haiyan Ge(Henan Cancer Hospital), Beibei Zhu(University of Kentucky), Donghao Lv(Wenzhou Medical University), Xuanzhu Zhao(Jiangsu Province Hospital)
Cited by 17
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
|Circulation|2007|2.9k
Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap
|Science|2018|1.2k
Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta‐analysis
|Hepatology|2017|876
<i>TRAF1–C5</i> as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study
|New England Journal of Medicine|2007|830